Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study.
Saved in:
| Title: | Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study. |
|---|---|
| Authors: | Fink, Morten1 (AUTHOR) anders.vittrup@oncology.au.dk, Vittrup, Anders Schwartz1 (AUTHOR) louise.guldbrandt@midt.rm.dk, Bastholt, Lars2 (AUTHOR) Lars.Bastholt@rsyd.dk, Svane, Inge Marie3 (AUTHOR) Inge.Marie.Svane@regionh.dk, Donia, Marco3 (AUTHOR) marco.donia@regionh.dk, Luczak, Adam A.4 (AUTHOR) adal@rn.dk, Ruhlmann, Christina H.5 (AUTHOR) christina.ruhlmann@rsyd.dk, Guldbrandt, Louise Mahncke1 (AUTHOR) uhk@braintrust-consult.dk, Koehler, Ulrich Heide1 (AUTHOR) henrschm@rm.dk, Winther, Mette Lerche2 (AUTHOR) mette.winther@hotmail.dk, Ellebaek, Eva3 (AUTHOR) eva.ellebaek.steensgaard@regionh.dk, Haslund, Charlotte Aaquist4 (AUTHOR) cah@rn.dk, Schmidt, Henrik1 (AUTHOR) |
| Source: | Cancers. Nov2021, Vol. 13 Issue 21, p5550. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
